Epithelial-mesenchymal transition spectrum quantification and its efficacy in deciphering survival and drug responses of cancer patients

Tan TZ1, Miow QH2, Miki Y3, Noda T3, Mori S3, Huang RY4, Thiery JP5 1Cancer Science Institute of Singapore, National University of Singapore, Singapore. 2Institute of Molecular and Cell Biology, A*STAR, Singapore. 3Cancer Institute of Japanese Foundation for Cancer Research, Kyoto, Japan. 4Cancer Science Institute of Singapore, National University of Singapore, Singapore Department of Obstetrics

The Runx-PU.1 pathway preserves normal and AML/ETO9a leukemic stem cells (Blood, Sept 2014)

Philipp B. Staber1, Pu Zhang1, Min Ye1, Robert S. Welner1, Elena Levantini2, Annalisa Di Ruscio1, Alexander K. Ebralidze1, Christian Bach1, Hong Zhang1, Junyan Zhang1, Katrina Vanura3, Ruud Delwel4, Henry Yang5, Gang Huang6, and Daniel G. Tenen1,5* 1 Harvard Stem Cell Institute, Harvard Medical School, Boston, MA, United States; 2 Institute of Biomedical Technologies, National Research

New batch of PhD students commences exciting new year at CSI

This year the institute admits a new intake of 8 high calibre PhD students into the CSI Graduate Program in Cancer Biology, especially welcoming 5 members hailing from various parts of the world including China, New Zealand and the United Kingdom. The group is joined by two attached PhD students from other NUS departments such as